European equities traded in the US as American depositary receipts kicked off the week higher late Monday morning, rising 0.57% to 1,657.92 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by brewing company Anheuser-Busch InBev (BUD) and lender Banco Santander (SAN), which advanced 2.3% and 1.5%, respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria (BBVA) and biopharmaceutical company DBV Technologies (DBVT), which were up 0.7% and 0.5%, respectively.

The decliners from continental Europe were led by biopharmaceutical company argenx (ARGX) and biotech firm Evaxion (EVAX), which fell 4.9% and 4.4%, respectively. They were followed by internet advertising firm Criteo (CRTO) and Sequans Communications (SQNS), which were down 3.1% and 2.2%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which rose 14% and 3.7%, respectively. They were followed by lender Barclays (BCS) and insurance company Prudential (PUK), which were 2.6% and 2.4%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Amarin (AMRN) and software firm Endava (DAVA), which dropped 3% and 2.2%, respectively. They were followed by medical device maker Smith & Nephew (SNN) and biopharmaceutical company Bicycle Therapeutics (BCYC), which increased 1.2% and 0.9%, respectively.